Biodegradable Plasmonic Nanoparticles for Cancer Imaging and Therapy

用于癌症成像和治疗的可生物降解的等离子体纳米颗粒

基本信息

项目摘要

DESCRIPTION (provided by applicant): It has been convincingly shown that nanotechnology can provide unique solutions to revolutionize diagnosis and treatment of many devastating diseases such as cancer. One specific area of great interest is development of nanoparticles for molecular specific imaging, therapy and combined imaging/therapy. A major roadblock in translation of inorganic nanoparticles to clinical practice for systemic targeting of cancer cells is their non-biodegradable nature. In addition, sizes of coated nanoparticles that are used in biological applications are not small enough to be easily cleared from the body. The accumulation and resulting long- term toxicity of nanoparticles is a major concern. In this research program we will create a new class of biodegradable gold nanoparticles with plasmon resonances in the NIR region. The nanoparticles will degrade to easily clearable components in the body and, therefore, will provide a crucial missing link between the enormous potential of metal nanoparticles for cancer imaging and therapy and translation into clinical practice. Our synthetic methodology is based on controlled assembly of very small (less than 5 nm) primary gold particles into nanoclusters with <100 nm overall diameter and an intense NIR absorbance. The assembly will be mediated by biodegradable polymers and small capping ligands on the primary nanoparticles. After delivery into the body the nanoclusters will biodegrade over time into sub-6 nm ligand capped primary gold nanoparticles, which will be highly favorable for rapid clearance from the body. This hybrid polymer/inorganic material will combine advantages of biodegradability of polymer nanoparticles and strong imaging contrast and therapeutic capabilities afforded by metal nanoparticles. Whereas these nanoclusters will be shown to have widespread potential in imaging/therapy, we will develop and optimize in this particular application biodegradable plasmonic nanoclusters with intense NIR absorbance for photo-acoustic imaging (PA) of cancerous cells. The nanoclusters will be evaluated in biologically relevant models of oral cancer. PUBLIC HEALTH RELEVANCE: It has been convincingly shown that nanotechnology can provide unique solutions to revolutionize diagnosis and treatment of many devastating diseases such as cancer. One specific area of great interest is development of nanoparticles for molecular specific imaging, therapy and combined imaging/therapy. A major roadblock in translation of inorganic nanoparticles to clinical practice for systemic targeting of cancer cells is their accumulation in the body and resulting long-term toxicity. In this research program we will create a new class of biodegradable gold nanoparticles with plasmon resonances in the NIR region. The nanoparticles will degrade to easily clearable components in the body and, therefore, will provide a crucial missing link between the enormous potential of metal nanoparticles for cancer imaging and therapy and translation into clinical practice.
描述(由申请人提供):已经令人信服地表明,纳米技术可以提供独特的解决方案,以彻底改变许多毁灭性疾病(如癌症)的诊断和治疗。非常感兴趣的一个特定领域是用于分子特异性成像、治疗和组合成像/治疗的纳米颗粒的开发。将无机纳米颗粒转化为用于癌细胞的全身靶向的临床实践的主要障碍是其不可生物降解的性质。此外,在生物应用中使用的包覆纳米颗粒的尺寸不够小,不能容易地从体内清除。纳米颗粒的累积和由此产生的长期毒性是一个主要问题。在这项研究计划中,我们将创建一类新的可生物降解的金纳米粒子与等离子体共振在近红外区域。纳米颗粒将降解为体内易于清除的成分,因此,将在金属纳米颗粒用于癌症成像和治疗的巨大潜力与转化为临床实践之间提供关键的缺失环节。我们的合成方法是基于非常小(小于5 nm)的初级金颗粒的控制组装成纳米团簇,具有<100 nm的总直径和强烈的近红外吸收。组装将由可生物降解的聚合物和初级纳米颗粒上的小封端配体介导。在递送到体内后,纳米团簇将随时间生物降解成亚6 nm配体封端的初级金纳米颗粒,这将非常有利于从体内快速清除。 这种杂化聚合物/无机材料将结合聚合物纳米颗粒的生物降解性和金属纳米颗粒提供的强成像对比度和治疗能力的联合收割机优点。鉴于这些纳米团簇将被证明在成像/治疗中具有广泛的潜力,我们将在此特定应用中开发和优化具有强NIR吸收的可生物降解等离子体纳米团簇,用于癌细胞的光声成像(PA)。纳米簇将在口腔癌的生物学相关模型中进行评估。 公共卫生相关性:纳米技术可以提供独特的解决方案,彻底改变许多毁灭性疾病(如癌症)的诊断和治疗。非常感兴趣的一个特定领域是用于分子特异性成像、治疗和组合成像/治疗的纳米颗粒的开发。将无机纳米颗粒转化为全身靶向癌细胞的临床实践的主要障碍是它们在体内的积累和导致的长期毒性。在这项研究计划中,我们将创建一类新的可生物降解的金纳米粒子与等离子体共振在近红外区域。纳米颗粒将降解为体内易于清除的成分,因此,将在金属纳米颗粒用于癌症成像和治疗的巨大潜力与转化为临床实践之间提供关键的缺失环节。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Konstantin V Sokolov其他文献

Nanobomb-assisted layer-specific optical coherence elastography
纳米弹辅助层特异性光学相干弹性成像
  • DOI:
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Maryam Hatami;Dmitry Nevozhay;Manmohan Singh;Alexander W. Schill;Paul Boerner;Konstantin V Sokolov;K. Larin
  • 通讯作者:
    K. Larin

Konstantin V Sokolov的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Konstantin V Sokolov', 18)}}的其他基金

iThera Medical Multispectral Optoacoustic Tomography System for Full Body Molecular and Functional Small Animal Imaging
iThera Medical 多光谱光声断层扫描系统,用于全身分子和功能性小动物成像
  • 批准号:
    8825823
  • 财政年份:
    2015
  • 资助金额:
    $ 29.19万
  • 项目类别:
Biodegradable Plasmonic Nanoparticles for Cancer Imaging and Therapy
用于癌症成像和治疗的可生物降解的等离子体纳米颗粒
  • 批准号:
    8404023
  • 财政年份:
    2010
  • 资助金额:
    $ 29.19万
  • 项目类别:
Biodegradable Plasmonic Nanoparticles for Cancer Imaging and Therapy
用于癌症成像和治疗的可生物降解的等离子体纳米颗粒
  • 批准号:
    8205011
  • 财政年份:
    2010
  • 资助金额:
    $ 29.19万
  • 项目类别:
Aptamer-siRNA Chimera/Nanoparticle Conjugates for MRI Guided Cancer Therapy
用于 MRI 引导癌症治疗的适体-siRNA 嵌合体/纳米颗粒缀合物
  • 批准号:
    7909734
  • 财政年份:
    2009
  • 资助金额:
    $ 29.19万
  • 项目类别:
Aptamer-siRNA Chimera/Nanoparticle Conjugates for MRI Guided Cancer Therapy
用于 MRI 引导癌症治疗的适体-siRNA 嵌合体/纳米颗粒缀合物
  • 批准号:
    7514833
  • 财政年份:
    2008
  • 资助金额:
    $ 29.19万
  • 项目类别:
Aptamer-siRNA Chimera/Nanoparticle Conjugates for MRI Guided Cancer Therapy
用于 MRI 引导癌症治疗的适体-siRNA 嵌合体/纳米颗粒缀合物
  • 批准号:
    7644393
  • 财政年份:
    2008
  • 资助金额:
    $ 29.19万
  • 项目类别:
Polarization Spectroscopy and Imaging of Pre-Cancer
癌症前期的偏振光谱和成像
  • 批准号:
    7064822
  • 财政年份:
    2005
  • 资助金额:
    $ 29.19万
  • 项目类别:
Polarization Spectroscopy and Imaging of Pre-Cancer
癌症前期的偏振光谱和成像
  • 批准号:
    7345411
  • 财政年份:
    2005
  • 资助金额:
    $ 29.19万
  • 项目类别:
Polarization Spectroscopy and Imaging of Pre-Cancer
癌症前期的偏振光谱和成像
  • 批准号:
    6928095
  • 财政年份:
    2005
  • 资助金额:
    $ 29.19万
  • 项目类别:
Polarization Spectroscopy and Imaging of Pre-Cancer
癌症前期的偏振光谱和成像
  • 批准号:
    7187356
  • 财政年份:
    2005
  • 资助金额:
    $ 29.19万
  • 项目类别:

相似海外基金

The earliest exploration of land by animals: from trace fossils to numerical analyses
动物对陆地的最早探索:从痕迹化石到数值分析
  • 批准号:
    EP/Z000920/1
  • 财政年份:
    2025
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Fellowship
Animals and geopolitics in South Asian borderlands
南亚边境地区的动物和地缘政治
  • 批准号:
    FT230100276
  • 财政年份:
    2024
  • 资助金额:
    $ 29.19万
  • 项目类别:
    ARC Future Fellowships
The function of the RNA methylome in animals
RNA甲基化组在动物中的功能
  • 批准号:
    MR/X024261/1
  • 财政年份:
    2024
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Fellowship
Ecological and phylogenomic insights into infectious diseases in animals
对动物传染病的生态学和系统发育学见解
  • 批准号:
    DE240100388
  • 财政年份:
    2024
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Discovery Early Career Researcher Award
Zootropolis: Multi-species archaeological, ecological and historical approaches to animals in Medieval urban Scotland
Zootropolis:苏格兰中世纪城市动物的多物种考古、生态和历史方法
  • 批准号:
    2889694
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Studentship
Using novel modelling approaches to investigate the evolution of symmetry in early animals.
使用新颖的建模方法来研究早期动物的对称性进化。
  • 批准号:
    2842926
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Studentship
Study of human late fetal lung tissue and 3D in vitro organoids to replace and reduce animals in lung developmental research
研究人类晚期胎儿肺组织和 3D 体外类器官在肺发育研究中替代和减少动物
  • 批准号:
    NC/X001644/1
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Training Grant
RUI: Unilateral Lasing in Underwater Animals
RUI:水下动物的单侧激光攻击
  • 批准号:
    2337595
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Continuing Grant
RUI:OSIB:The effects of high disease risk on uninfected animals
RUI:OSIB:高疾病风险对未感染动物的影响
  • 批准号:
    2232190
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Continuing Grant
A method for identifying taxonomy of plants and animals in metagenomic samples
一种识别宏基因组样本中植物和动物分类的方法
  • 批准号:
    23K17514
  • 财政年份:
    2023
  • 资助金额:
    $ 29.19万
  • 项目类别:
    Grant-in-Aid for Challenging Research (Exploratory)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了